Skip to main content
Clinical Trials/NL-OMON54791
NL-OMON54791
Recruiting
Not Applicable

Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma (ETERNITY). - Determinants of long-term survival in glioblastoma

European Organisation for Research in Treatment of Cancer (EORTC)0 sites73 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
glioblastoma
Sponsor
European Organisation for Research in Treatment of Cancer (EORTC)
Enrollment
73
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
European Organisation for Research in Treatment of Cancer (EORTC)

Eligibility Criteria

Inclusion Criteria

  • \- Age \> 18 years at diagnosis
  • \- Histopathological diagnosis of glioblastoma (reference histology available)
  • \- Survival \>5 years from diagnosis
  • \- Availability of tumor tissue from initial glioblastoma diagnosis (FFPE or
  • fresh\-frozen) to validate the diagnosis centrally
  • \- Signed consent form (living patients) or no documentation of previous
  • objection of the patient to any of these purposes, and the meaningful aim of
  • the data / material collection and use to research (deceased patients), and a
  • notification to an ethics committee for the re\-use of these data and samples,
  • and any other national requirements

Exclusion Criteria

  • Optional stool collection for in\-living caregivers
  • \- Cancer in the past 3 years (carcinomas in situ in the past 3 years are
  • \- IBD (Inflammatory Bowel Disease) e.g. Crohn, Colitis Ulcerosa
  • \- Medications for gastro\-intestinal motility within the last 3 months
  • \- Systemic Antibiotics within the last month
  • \- Systemic corticosteroids
  • \- Previous extensive gastro\-intestinal surgery
  • \- Use of probiotics containing live bacteria or yeast
  • \- Consent of another caregiver of the same patient

Outcomes

Primary Outcomes

Not specified

Similar Trials